January 23, 2020
-
A drug must meet all four of the rule criteria to be considered for inclusion on the HHSC specialty drug list (SDL). The SDL includes drugs MCOs may exclusively provide through their specialty pharmacy network.
-
January 17, 2020
-
Pharmacy providers should expect a delay in state payment because of the upcoming federal bank holiday.
-
VDP will modify the Austedo prior authorization criteria on March 3. The criteria are included within the existing Vesicular Monoamine Transporter 2 (VMAT2) Inhibitors criteria guide. The class includes Austedo, Xenazine and Ingrezza.
January 16, 2020
-
In 2019, the Texas State Legislature passed House Bill 2536 relating to drug cost transparency. It requires pharmaceutical drug manufacturers to report certain cost information on U.S. Food and Drug Administration-approved drugs sold in or into Texas.
January 15, 2020
-
VDP will revise the Allergen Extracts clinical prior authorization criteria on Feb. 24 to reflect the FDA guidance expanding the indication for Oralair.
-
VDP will implement the Rinvoq (upadacitinib) clinical prior authorization criteria on March 3.
January 14, 2020
-
The quarterly crosswalk identifies relationships between National Drug Codes and Medicaid payable Healthcare Common Procedure Coding System codes.
January 10, 2020
January 7, 2020
-
HHSC requires application fees for pharmacies enrolling with Texas Medicaid.
January 2, 2020
-
-
Our drug shortage notification process is available for pharmacy staff to notify HHSC about potential drug shortages that impact prescribing choice and pharmacy claim processing
-
Texas Health Steps provides resources for primary care providers and other health professionals, including a pharmacy continuing education course available for credit and two new quick courses:
-
Important reminders for pharmacy staff about Medicaid pharmacy benefits.
-
Pharmacy providers should expect increased controlled substance e-prescriptions and are encouraged to be certain that all staff are informed on accepting and dispensing these e-prescriptions, including CII e-prescription requirements.